“EVALUATION OF THE ROLE OF FECAL CALPROTECTIN AS A BIOMARKER OF ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH CROHN’S DISEASE ” (2026) Global Journal of Public Health Medicine, 8(1 (Ongoing), pp. 216–227. doi:10.37557/33f44713.